Effect of an intravitreal dexamethasone implant on diabetic macular edema after cataract surgery

41Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: To analyze the effects of a dexamethasone intravitreal implant (DEX; Ozurdex 700 mg; Allergan) administered immediately after cataract surgery in diabetic patients. Methods: This prospective, single-arm, open label study (NCT01748487 at ClinicalTrials. gov) involved Type 2 diabetic patients with at least mild diabetic retinopathy (DR) who underwent cataract surgery and DEX insertion after phacoemulsification, and intraocular lens implantation were enrolled. Best-corrected visual acuity and central retinal thickness (CRT) measured by spectral-domain optical coherence tomography were recorded at 1 week preoperatively, and 1 week, 1 month, and 3 months after surgery. Adverse events were also recorded. Results: Twenty-four eyes of 24 patients (17 [70.8%] men; mean age 63.7 ± 8.7 years) with mild nonproliferative DR (41.7%), moderate nonproliferative DR (33.3%), severe nonproliferative DR (16.7%), or treated proliferative DR (8.3%) were selected. After DEX treatment, mean CRT changed from 241.1 mm (95% confidence interval, 227.5–254.6 mm) at baseline to 236.9 mm (95% confidence interval, 223.9–249.9 mm) at 1 week (P = 0.09), 238.9 mm (95% confidence interval, 225.5–252.3 mm) at 1 month (P = 0.44), and 248 mm (95% confidence interval, 232.4–260.8 mm) at 3 months (P = 0.15). No eyes showed a postoperative increase .50 mm in the CRT at any visit. A 10% increase in CRT was found in 8.3% of eyes. Mean best-corrected visual acuity significantly improved from 0.37 (20/50) at baseline to 0.19 (20/30) at 1 week, 0.12 (20/25) at 1 month, and 0.12 (20/25) at 3 months (P, 0.001 for each comparison). Mean intraocular pressure before surgery was 13.8 mmHg, and none of the patients developed an intraocular pressure $22 mmHg at any visit. None of the patients developed any serious adverse events during the follow-up. Conclusion: These short-term results suggest that a single DEX injection intraoperatively after phacoemulsification could avoid an increase in CRT after cataract surgery in diabetic patients.

Cite

CITATION STYLE

APA

Calvo, P., Ferreras, A., Al Adel, F., Dangboon, W., & Brent, M. H. (2018). Effect of an intravitreal dexamethasone implant on diabetic macular edema after cataract surgery. Retina, 38(3), 490–496. https://doi.org/10.1097/IAE.0000000000001552

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free